We used anti-PRR was radiolabeled with 125I, and tumor targeting was analyzed by SPECT/CT in mice bearing subcutaneous human pancreatic cancer xenografts, and genetically engineered mouse model of pancreatic cancer, Pdx1-cre; LSL-KrasG12D mice. This evidence concerns the gene ATP6AP2 and pancreatic neoplasm.